cancer

McKesson Forms Joint Venture with HCA Healthcare to Fight Cancer

by | Jun 23, 2022
Two giants in their industry are teaming up to accelerate cancer research. The new joint venture is an "important step forward" to increase access to clinical trials, says McKesson CEO Brian Tyler, McKesson CEO. Separate from the joint venture deal, McKesson will acquire Genospace, a personalized precision medicine platform that’s part of HCA’s research institute.
MORE
Dallas’ Lupagen Aims To Change the Way Cancer, Other Disorders Are Treated
by | Jun 2, 2022
Instead of shipping a patient's blood to a lab for customized cell therapy, Lupagen does the procedure "in vivo," using a dialysis-like treatment at the patient's bedside. Now it's collaborating with Umoja Biopharma to use its drug-delivery tech to place targeted immunotherapies in patients.

“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
MORE
Westlake’s Virbac Announces Availability of New Dog Cancer Treatment Across the U.S.
by | Aug 16, 2021
Stelfonta received FDA approval last November to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs)—the most common malignant skin tumor in dogs. The injection is now available at vet clinics across the U.S., with an 88% "satisfactory experience" rate to date.
MORE
Southlake Biotech OncoNano Medicine Raises $50M in Series B to Accelerate Cancer Tech Toward Commercialization
by | Jun 17, 2021
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
MORE

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

by | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
MORE
TWU Biology Team Granted a Patent for Anti-Cancer Compounds That Could Save Lives
by | Oct 15, 2020
The novel invention from researchers at Texas Woman’s University in Denton could greatly contribute to cancer treatment research. The compounds can prevent the growth of breast, lung, and colon cancer cells.
MORE
Dialectic
Dialectic Therapeutics Plans to Further Cancer Drug Research Using $3M Seed Award
by | Feb 26, 2020
Using innovative new technologies and targeted therapies, the Dallas biotech startup aims to help patients with cancer, give them hope, and prolong their lives.
MORE
Caris Life Sciences
Caris Life Sciences Launches AI-Driven Profiling Tool for Tumors
by | Dec 12, 2019
The Genomic Profiling Similarity Score uses over 6,500 mathematical models in a machine learning algorithm to compare molecular characteristics of a patient's tumor against Caris' extensive database.
MORE
Lantern Pharma cancer

Lantern Pharma Teams Up with National Cancer Institute to Predict Drug Effectiveness on Tumors

by | Oct 7, 2019
This alum of Dallas startup accelerator Health Wildcatters is working with the National Cancer Institute's Developmental Therapeutics Branch on precision research and treatments.
MORE
research oak trees
Discovery: UNT Finds Oak Trees Scrub Black Carbon From Atmosphere, UTSW’s Obesity Research Leads to Surprise
by | Sep 6, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also find how work involving a UT Arlington professor's research shows promise in treating deep-seated tumors.
MORE
cancer Mary Kay
Mary Kay Foundation Awards UTSW $500K Grant to Find Cures for Women-Related Cancers
by | Sep 6, 2019
The one-year fellowships will support up to five international postdoctoral researchers in conducting cutting-edge cancer research at UT Southwestern in Dallas.
MORE
biomedical
UNT Opens $12.6M Cutting-Edge Biomedical Engineering Building
by | Aug 30, 2019
The 26,500-square-foot facility has labs for research in exoskeleton technology, optics, and a bio 3D printer for printing cells that mimic human tissue.
MORE
water research

Discovery: UTA Seeks Best Way to Recycle Fracking Wastewater; UNT Professor Tackles Global Food Insecurity

by | Aug 16, 2019
You’ll also find out about research at UT Southwestern that suggests timing and dosage changes might have a positive effect in treating some cancers in this roundup of research and development activity in North Texas.
MORE
Discovery: UTA, Lockheed Work on UVA Sensor Research; Parkland Center Joins Kidney Disease Initiative
by | Aug 2, 2019
You'll also find out about a team at UT Southwestern Medical Center that is working on new approaches to prevent and treat colorectal cancer in this roundup of research and development activity in North Texas.
MORE
cancer research
Discovery: UTD Works to Make Nanomedicines Safer; UTSW’s Breakthrough in Cancer Research
by | Jul 26, 2019
Also, you’ll find out about how a UTA researcher will use a $634,000 grant to study T cells’ role in cardiovascular disease in older people, as well as two UTD scientists who have received honors in this roundup of research and development activity in North Texas.
MORE
surgeons SMU
SMU Researchers Among Team Using Video Game Tech to Fight Cancer in Africa
by | Jul 26, 2019
The team's virtual reality simulation places novice surgeons inside a surgical theater in Zambia to learn the intricacies of performing a hysterectomy to battle cervical cancer.
MORE